Cargando…
Immunogenicity and Toxicity of Different Adjuvants Can Be Characterized by Profiling Lung Biomarker Genes After Nasal Immunization
The efficacy of vaccine adjuvants depends on their ability to appropriately enhance the immunogenicity of vaccine antigens, which is often insufficient in non-adjuvanted vaccines. Genomic analyses of immune responses elicited by vaccine adjuvants provide information that is critical for the rational...
Autores principales: | Sasaki, Eita, Asanuma, Hideki, Momose, Haruka, Furuhata, Keiko, Mizukami, Takuo, Hamaguchi, Isao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7516075/ https://www.ncbi.nlm.nih.gov/pubmed/33013912 http://dx.doi.org/10.3389/fimmu.2020.02171 |
Ejemplares similares
-
Nasal alum-adjuvanted vaccine promotes IL-33 release from alveolar epithelial cells that elicits IgA production via type 2 immune responses
por: Sasaki, Eita, et al.
Publicado: (2021) -
Development of a preclinical humanized mouse model to evaluate acute toxicity of an influenza vaccine
por: Sasaki, Eita, et al.
Publicado: (2018) -
Modeling for influenza vaccines and adjuvants profile for safety prediction system using gene expression profiling and statistical tools
por: Sasaki, Eita, et al.
Publicado: (2018) -
Changes of urine metabolite profiles are induced by inactivated influenza vaccine inoculations in mice
por: Sasaki, Eita, et al.
Publicado: (2019) -
Establishment of a New Quality Control and Vaccine Safety Test for Influenza Vaccines and Adjuvants Using Gene Expression Profiling
por: Momose, Haruka, et al.
Publicado: (2015)